4ALG | pdb_00004alg

N-Terminal Bromodomain of Human BRD2 With IBET-151


Experimental Data Snapshot

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.60 Å
  • R-Value Free: 
    0.202 (Depositor), 0.206 (DCC) 
  • R-Value Work: 
    0.176 (Depositor), 0.184 (DCC) 
  • R-Value Observed: 
    0.177 (Depositor) 

wwPDB Validation 3D Report Full Report

Validation slider image for 4ALG

Ligand Structure Quality Assessment 


This is version 1.2 of the entry. See complete history

Literature

Identification of a Novel Series of Bet Family Bromodomain Inhibitors: Binding Mode and Profile of I-Bet151 (Gsk1210151A).

Seal, J.Lamotte, Y.Donche, F.Bouillot, A.Mirguet, O.Gellibert, F.Nicodeme, E.Krysa, G.Kirilovsky, J.Beinke, S.Mccleary, S.Rioja, I.Bamborough, P.Chung, C.Gordon, L.Lewis, T.Walker, A.L.Cutler, L.Lugo, D.Wilson, D.M.Witherington, J.Lee, K.Prinjha, R.K.

(2012) Bioorg Med Chem Lett 22: 2968

  • DOI: https://doi.org/10.1016/j.bmcl.2012.02.041
  • Primary Citation Related Structures: 
    4AKN, 4ALG

  • PubMed Abstract: 

    A novel series of quinoline isoxazole BET family bromodomain inhibitors are discussed. Crystallography is used to illustrate binding modes and rationalize their SAR. One member, I-BET151 (GSK1210151A), shows good oral bioavailability in both the rat and minipig as well as demonstrating efficient suppression of bacterial induced inflammation and sepsis in a murine in vivo endotoxaemia model.


  • Organizational Affiliation
    • Epinova DPU, GlaxoSmithKline R&D, Medicines Research Centre, Stevenage, Hertfordshire, UK. jon.t.seal@gsk.com

Macromolecule Content 

  • Total Structure Weight: 18.48 kDa 
  • Atom Count: 1,166 
  • Modeled Residue Count: 118 
  • Deposited Residue Count: 154 
  • Unique protein chains: 1

Macromolecules

Find similar proteins by:|  3D Structure
Entity ID: 1
MoleculeChains  Sequence LengthOrganismDetailsImage
BROMODOMAIN-CONTAINING PROTEIN 2154Homo sapiensMutation(s): 0 
UniProt & NIH Common Fund Data Resources
Find proteins for P25440 (Homo sapiens)
Explore P25440 
Go to UniProtKB:  P25440
PHAROS:  P25440
GTEx:  ENSG00000204256 
Entity Groups
Sequence Clusters30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt GroupP25440
Sequence Annotations
Expand
Reference Sequence

Small Molecules

Ligands 3 Unique
IDChains Name / Formula / InChI Key2D Diagram3D Interactions
1GH

Query on 1GH



Download:Ideal Coordinates CCD File
D [auth A]7-(3,5-DIMETHYL-1,2-OXAZOL-4-YL)-8-METHOXY-1-[(1R)-1-(PYRIDIN-2-YL)ETHYL]-1H,2H,3H-IMIDAZO[4,5-C]QUINOLIN-2-ONE
C23 H21 N5 O3
VUVUVNZRUGEAHB-CYBMUJFWSA-N
GOL

Query on GOL



Download:Ideal Coordinates CCD File
C [auth A]GLYCEROL
C3 H8 O3
PEDCQBHIVMGVHV-UHFFFAOYSA-N
ACT

Query on ACT



Download:Ideal Coordinates CCD File
B [auth A]ACETATE ION
C2 H3 O2
QTBSBXVTEAMEQO-UHFFFAOYSA-M

Experimental Data & Validation

Experimental Data

  • Method: X-RAY DIFFRACTION
  • Resolution: 1.60 Å
  • R-Value Free:  0.202 (Depositor), 0.206 (DCC) 
  • R-Value Work:  0.176 (Depositor), 0.184 (DCC) 
  • R-Value Observed: 0.177 (Depositor) 
Space Group: C 1 2 1
Unit Cell:
Length ( Å )Angle ( ˚ )
a = 82.05α = 90
b = 40.303β = 113.22
c = 48.347γ = 90
Software Package:
Software NamePurpose
REFMACrefinement
MOSFLMdata reduction
SCALAdata scaling

Structure Validation

View Full Validation Report



Ligand Structure Quality Assessment 


Entry History 

Deposition Data

Revision History  (Full details and data files)

  • Version 1.0: 2012-07-04
    Type: Initial release
  • Version 1.1: 2019-05-15
    Changes: Data collection, Experimental preparation, Other
  • Version 1.2: 2024-05-08
    Changes: Data collection, Database references, Derived calculations, Other